XML 21 R17.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Earnings Per Share | 3 Months Ended
--- | ---
Dec. 28, 2019
Earnings Per Share [Abstract] |
Earnings Per Share | Earnings Per Share The following is a reconciliation of the numerators and denominators of the basic and diluted per share computations for income from continuing operations (in thousands except share and per share amounts).
|  | Three Months Ended |  |  |  |  |  |  |  |  |  |
|  | December 28, 2019 |  |  |  |  |  |  |  |  |  |
|  | Income |  | Shares |  | Per Share |  |  |  |  |  |
Basic EPS: |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) available to common shareholders |  | $ | (4,417) |  |  | 54,755 |  |  | $ | (0.08) |  |  |  |  |  |  |
Effect of dilutive securities (1): |  |  |  |  |  |  |  |  |  |  |  |
Options to purchase common stock |  | — |  |  | — |  |  | — |  |  |  |  |  |  |
Restricted shares |  | — |  |  | — |  |  | — |  |  |  |  |  |  |
Diluted EPS: |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) available to common shareholders |  | $ | (4,417) |  |  | 54,755 |  |  | $ | (0.08) |  |  |  |  |  |  |
(1) The potential effects of stock awards were excluded from the diluted earnings per share calculation for the three months ended December 28, 2019, because their inclusion in a net loss period would be anti-dilutive to the earnings per share calculation.
|  | Three Months Ended |  |  |  |  |  |  |  |  |  |
|  | December 29, 2018 |  |  |  |  |  |  |  |  |  |
|  | Income |  | Shares |  | Per Share |  |  |  |  |  |
Basic EPS: |  |  |  |  |  |  |  |  |  |  |  |
Net income available to common shareholders |  | $ | 1,803 |  |  | 56,903 |  |  | $ | 0.03 |  |  |  |  |  |  |
Effect of dilutive securities: |  |  |  |  |  |  |  |  |  |  |  |
Options to purchase common stock |  | — |  |  | 667 |  |  | — |  |  |  |  |  |  |
Restricted shares |  | — |  |  | 431 |  |  | — |  |  |  |  |  |  |
Diluted EPS: |  |  |  |  |  |  |  |  |  |  |  |
Net income available to common shareholders |  | $ | 1,803 |  |  | 58,001 |  |  | $ | 0.03 |  |  |  |  |  |  |
Options to purchase 2.6 million shares of common stock at prices ranging from $8.56 to $38.10 per share were outstanding at December 28, 2019, and options to purchase 2.3 million shares of common stock at prices ranging from $6.43 to $38.10 per share were outstanding at December 29, 2018. For the three months ended December 28, 2019 and December 29, 2018, 1.0 million and 1.1 million options outstanding were not included in the computation of diluted earnings per share because the option exercise prices were greater than the average market price of the common shares and therefore, the effect of including these options would be antidilutive. For the three months ended December 28, 2019, 0.4 million options outstanding and 0.3 million restricted shares were excluded from the diluted earnings per share calculation for the three months ended December 28, 2019, because their inclusion in a net loss period would be anti-dilutive to the earnings per share calculation.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration